期刊文献+

新型隐球菌及念珠菌临床分离株对5种抗真菌药物的体外敏感性 被引量:4

In vitro susceptibility of Cryptococcus neoformans and Candida species to five antifungal drugs
原文传递
导出
摘要 目的 了解临床分离的新型隐球菌和念珠菌对氟康唑、两性霉素B、伊曲康唑、氟胞嘧啶和酮康唑的体外敏感性及与临床治疗效果的相关性。方法 采用标准微量稀释法测定了上述 5种抗真菌药物对临床分离株的 35株新型隐球菌和 5 6株念珠菌属的最低抑菌浓度 (MIC)。结果  5 6株念珠菌对 5种药物的敏感性 (MIC)分别为氟康唑 0 .12 5~ 6 4μg/ml,94.6 %的菌株对氟康唑敏感 ,1.8%为剂量依赖性敏感 ,3.6 %耐药 ;伊曲康唑 0 .0 3~ 1μg/ml,5 7.1%敏感 ,37.5 %剂量依赖性敏感 ,5 .4%耐药 ;氟胞嘧啶 0 .12 5~ 32 μg/ml,92 .8%敏感 ,3.6 %中度敏感 ,3.6 %耐药 ;两性霉素B 0 .0 6~2 μg/ml;酮康唑 0 .0 3~ 0 .5 μg/ml。 35株新型隐球菌对 5种药物的MIC范围分别为氟康唑 2~ 6 4μg/ml,伊曲康唑 0 .2 5~ 1μg/ml,两性霉素B 0 .0 3~ 1μg/ml,氟胞嘧啶 0 .2 5~ 6 4μg/ml,酮康唑 0 .12 5 ~ 1μg/ml。 Objective To study the in vitro susceptibilities of Cryptococcus neoformans and Candida species collected from clinical samples (cerebrospinal fluid, sputum, urine and stool) to fluconazole, amphotericin B, itraconazole, 5 flucytosine and ketoconazole. The consistence of susceptibilities and clinical treatment efficacy was also evaluated. Methods 35 isolates of Cryptococcus neoformans and 56 isolates of Candida species were tested for their susceptibilities to five antifungal agents by broth microdilution method according to the National Committee of Clinical Laboratory Standard Recommendations (document M27 A). Results The susceptibilities of 56 isolates of Candida species to five antifungal agents were listed as follows: fluconazole 0.125~64 μg/ml , 94.6% of them were susceptible, 1.8% were dose dependent susceptible, 3.6% were resistant; itraconazole 0.03~1 μg/ml, 57.1% were susceptible, 37.5% were dose dependent susceptible, 5.4% were resistant; 5 flucytosine 0.125~32 μg/ml, 92.8% were susceptible, 3.6% were intermediate sensitive, 3.6% were resistant; amphotericin B 0.06~2 μg/ml, ketoconazole 0.03~0.5 μg/ml. The MIC ranges of 35 isolates of Cryptococcus neoformans were: fluconazole 2~ 64 μg/ml, itraconazole 0.25~1 μg/ml, amphotericin B 0.03~1 μg/ml, 5 flucytosine 0.25~64 μg/ml, ketoconazole 0.125 ~1 μg/ml.Conclusions The MICs of five antifungal drugs for Cryptococcus neoformans and Candida species obtained by the NCCLS M27 A method were consistent and could be reproduced.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2000年第4期239-243,共5页 Chinese Journal of Infectious Diseases
关键词 抗真菌药物 药敏试验 新型隐球菌 念珠菌属 Antifungal susceptibility test Minimum inhibitory concentration Cryptococcus neoformans Candida species Microdilution
  • 相关文献

参考文献1

共引文献2

同被引文献14

  • 1徐红,陈裕充,温海,陈江汉.Neo-Sensitab纸片法与微量稀释法检测常见酵母菌对酮康唑敏感性的比较[J].检验医学,2004,19(5):385-386. 被引量:7
  • 2吴绍熙,郭宁如,沈永年,吕桂霞.国产氟康唑抗真菌药效学研究[J].中华皮肤科杂志,1994,27(2):80-82. 被引量:13
  • 3李仲兴 郑家齐.诊断细菌学[M].香港:黄河文化出版社,1992.295-297.
  • 4Kullberg B J,Oude Lashof A M.Epidemiology of opportunistic invasive mycoses[J].Eur J Med Res,2002,7 (5):183.
  • 5National committee for clinical laboratory standards.Reference methed for broth dilution antifungal susceptibility testing of yeasts:approved standard M27-A[S].NCCLS,1997,17(9):1.
  • 6National committee for clinical laboratory standards.Development of in vitro susceptibility testing criteria and quality control parameters:tentative guideline M23-T3[S].NCCLS,1998.
  • 7Moore C B,Oakley K L,Denning D W.In vitro activity of a new echinocandin,LY303366,and comparison with fluconazole,flucytosine and amphotericin B against Candida species[J].Clin Microbiol Infect,2001,7 (1):11.
  • 8Rex J H,Cooper C R Jr,Merz W G,et al.Detection of amphotericin B-resistant Candida isolates in a broth-based system[J].Antimicrob Agents Chemother,1995,39(4):906.
  • 9Colombo A L,Barchiesi F,Mcgough D A,et al.Comparison of Etest and national committee for clinical laboratory standards broth macrodilution method for azole antifungal susceptibility testing[J].J Clin Microbiol,1995,33 (3):535.
  • 10Sandven P.Detection of fluconazole-resistant Candida strains by a disc diffusion screening test[J].J Clin Microbiol,1999,37 (12):3856.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部